|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...38394041424344454647484950 |
- Biomarker, Trial completion: Pharmacogenetics of Antiretroviral Drugs (clinicaltrials.gov) - Aug 23, 2011
P4, N=200, Completed, Sponsor: Cliniques universitaires Saint-Luc- Universit
Not yet recruiting --> Completed
- | faldaprevir (BI201335) / Boehringer Ingelheim
Trial completion: Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers (clinicaltrials.gov) - Aug 22, 2011
P1, N=14, Completed, Sponsor: Boehringer Ingelheim
Not yet recruiting --> Completed Recruiting --> Completed
- ||||| Intelence (etravirine) / J&J
New P4 trial, Combination therapy, IO biomarker: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients (clinicaltrials.gov) - Aug 21, 2011
P4, N=220, Completed, Sponsor: Janssen R&D Ireland
- Selzentry (maraviroc) / ViiV Healthcare, Isentress (raltegravir) / Merck (MSD)
New P2 trial: ROCnRAL: Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy (clinicaltrials.gov) - Aug 17, 2011
P2, N=48, Terminated, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
- | Tivicay (dolutegravir) / ViiV Healthcare
New P1 trial: Drug Interaction Study Between Dolutegravir and Prednisone (clinicaltrials.gov) - Aug 17, 2011
P1, N=12, Completed, Sponsor: ViiV Healthcare
- || Enrollment closed: Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV (clinicaltrials.gov) - Aug 16, 2011
P=N/A, N=120, Active, not recruiting, Sponsor: University Hospitals of Cleveland
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial suspension: MRSA-2: Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection (clinicaltrials.gov) - Aug 14, 2011
P=N/A, N=60, Suspended, Sponsor: Uniformed Services University of the Health Sciences
Recruiting --> Active, not recruiting Recruiting --> Suspended
- New P4 trial: PrOMPT: Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (clinicaltrials.gov) - Aug 14, 2011
P4, N=44, Terminated, Sponsor: Prof JMA Lange
- | New P4 trial: IDEAL-Study: Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (clinicaltrials.gov) - Aug 14, 2011
P4, N=210, Recruiting, Sponsor: Universit
- mupirocin / Generic mfg.
Enrollment closed: Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons (clinicaltrials.gov) - Aug 14, 2011
P=N/A, N=550, Active, not recruiting, Sponsor: Uniformed Services University of the Health Sciences
Recruiting --> Suspended Recruiting --> Active, not recruiting
- Enrollment open: A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV (clinicaltrials.gov) - Aug 11, 2011
P2, N=750, Recruiting, Sponsor: Nova Southeastern University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial completion: SWIM: Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study (clinicaltrials.gov) - Aug 11, 2011
P=N/A, N=120, Completed, Sponsor: London School of Hygiene and Tropical Medicine
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion: Integration of Family Planning and HIV Services in Tanzania (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=864, Completed, Sponsor: FHI 360
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs (clinicaltrials.gov) - Aug 8, 2011
P2, N=746, Completed, Sponsor: Johns Hopkins Bloomberg School of Public Health
Recruiting --> Completed Active, not recruiting --> Completed
- Epogen (epoetin alfa) / Amgen
Trial withdrawal: Epoetin Alfa for HIV-Associated Neuropathy Trial (clinicaltrials.gov) - Aug 7, 2011
P2, N=0, Withdrawn, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Terminated --> Withdrawn
- Trial termination: Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=26, Terminated, Sponsor: Mount Sinai School of Medicine
Terminated --> Withdrawn Recruiting --> Terminated; low enrollment
- Enrollment change: Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=26, Terminated, Sponsor: Mount Sinai School of Medicine
Recruiting --> Terminated; low enrollment N=60 --> 26
- ||||| New P2 trial: Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings (clinicaltrials.gov) - Aug 7, 2011
P2, N=270, Completed, Sponsor: Novartis Vaccines
- Trial completion: Evaluation of 2 Interferon ? Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT (clinicaltrials.gov) - Aug 7, 2011
P4, N=240, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=60 --> 26 Terminated --> Completed
- Trial completion: HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV (clinicaltrials.gov) - Aug 7, 2011
P4, N=54, Completed, Sponsor: AIDS Clinical Trials Group
Terminated --> Completed Active, not recruiting --> Completed